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Multiphoton microscopy has been widely used for in-vivo tissue imaging of various biological studies. However, 
its application to clinical studies has been limited due to either lack of clinically compatible exogenous contrast 
agents or weak autofluorescence of tissues. We investigated moxifloxacin as a contrast agent of cells for 
multiphoton tissue imaging. Moxifloxacin is an FDA approved antibiotic with relatively good pharmacokinetic 
properties for tissue penetration and intrinsic fluorescence. Two-photon microscopy (TPM) of moxifloxacin 
treated mouse corneas showed good tissue penetration and high concentration inside the corneal cells [1]. Cell 
labeling of moxifloxacin was tested in both cultured cells and isolated immune cells. Moxifloxacin tissue 
applications were tested in various mouse organs such as the skin, small intestine, and brain. Most of tissues 
were labeled well via topical administration, and only the skin required additional gentle removal of the outermost 
stratum corneum by tape stripping. TPM of these tissues showed non-specific cell labeling of moxifloxacin and 
fluorescence enhancement [2]. Although most of experimental results were from mouse tissues, its clinical 
application would be possible. Clinical application is promising since imaging based on moxifloxacin labeling 
could be 10 times faster than imaging based on endogenous fluorescence. 
 
Moxifloxacin labeling of cultured cells was demonstrated by comparing TPM images with and without 
moxifloxacin treatment. Bright fluorescence inside cells were observed only with moxifloxacin at the same 
imaging condition. TPM of the skin dermis visualized many dermal cells with increased fluorescence, and TPM 






Figure 1 – Moxifloxacin labeling of cell 
cultures and tissues 
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